Last checked at 10 Nov 2017 07:00
10 November 2017
Byotrol plc
GRANT OF OPTIONS
DIRECTOR SHAREHOLDINGS
The Board of Byotrol plc ('Byotrol' or the 'Company'), the specialist anti-microbial technology company, announces that on 9 November 2017, it granted a total of 10,296,750 options over the Company's ordinary shares of 0.25 pence each ("Options" and "Ordinary Shares" respectively) representing 2.56 per cent. of the issued share capital of the Company to two Directors and certain employees of the Company, upon the recommendation of the Company's Remuneration Committee.
Details of the awards to the two Directors and a PDMR of the Company are set out below (the "Director/PDMR Options"):
| Position | No. of New Options Granted | No. of Options held post Grant | Shareholding in Company | Percentage of fully diluted share capital |
David Traynor | Chief Executive | 1,000,000 | 6,900,000 | 4,850,514 | 2.92% |
Dr Trevor Francis | Chief Technology Officer | 2,375,000 | 6,325,000 | 2,253,216 | 2.13% |
Denise Keenan | Head of Finance (PDMR) | 1,792,500 | 3,217,500 | - | 0.80% |
TOTAL |
| 5,167,500 |
|
| 5.85% |
The above Director/PDMR Options, which are exercisable at 4 pence per Ordinary Share over a seven year period, vest on the following basis;
· -30% vest after 12 months if the mid - share price averages over 5p for a 30 day period
· 35% vest after 24 months if the mid - share price averages over 7.5p for a 30 day period
· 35% vest after 36 months if the mid - share price averages over 10p for a 30 day period
The 5,167,500 Director/PDMR Options are being granted under the Company's Enterprise Management Incentive Scheme.
The remaining 5,129,250 Options are being awarded to a number of key employees of the Company ("Employee Options"). These Employee Options are also exercisable at 4 pence per Ordinary Share between 9 November 2018 and expire in tranches up to 9 May 2025. All 10,296,750 Options granted today will vest on any change of control of the Company.
Following the grant of the 10,296,750 Options, there will be 35,244,250 Options in issue representing 8.75% per cent. of the Company's issued share capital.
Enquiries:
Byotrol plc | 01925 742 000 |
John Langlands - Chairman David Traynor - Chief Executive
|
|
|
|
|
|
finnCap Ltd | 020 7220 0500 |
Geoff Nash / Carl Holmes / James Thompson- Corporate Finance |
|
Stephen Norcross / Richard Chambers - Corporate Broking |
|
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.
Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens.
Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.
For more information, please go to www.byotrol.co.uk
Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | David Traynor |
2. | Reason for the Notification | |
a) | Position/status | Chief Executive |
b) | Initial notification/Amendment | Initial |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Byotrol Plc |
b) | LEI | 213800AJMTSTIPA59A34 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the Financial instrument, type of instrument | options over ordinary shares of 0.25p each |
Identification code | GB00B0999995 | |
b) | Nature of the transaction | Award of Options to subscribe for Ordinary Shares |
c) | Price(s) and volume(s) | Volume - 1,000,000 Exercise Price - 4 pence |
d) | Aggregated information: | See 4c) above |
e) | Date of the transaction | 9 November 2017 |
f) | Place of the transaction | Outside of a trading venue |
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Dr Trevor Francis |
2. | Reason for the Notification | |
a) | Position/status | Chief Technology Officer |
b) | Initial notification/Amendment | Initial |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Byotrol Plc |
b) | LEI | 213800AJMTSTIPA59A34 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the Financial instrument, type of instrument | options over ordinary shares of 0.25p each |
Identification code | GB00B0999995 | |
b) | Nature of the transaction | Award of Options to subscribe for Ordinary Shares |
c) | Price(s) and volume(s) | Volume - 2,375,000 Exercise Price - 4 pence |
d) | Aggregated information: | See 4c) above |
e) | Date of the transaction | 9 November 2017 |
f) | Place of the transaction | Outside of a trading venue |
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Denise Keenan |
2. | Reason for the Notification | |
a) | Position/status | Head of Finance and Company Secretary (PDMR) |
b) | Initial notification/Amendment | Initial |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Byotrol Plc |
b) | LEI | 213800AJMTSTIPA59A34 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the Financial instrument, type of instrument | options over ordinary shares of 0.25p each |
Identification code | GB00B0999995 | |
b) | Nature of the transaction | Award of Options to subscribe for Ordinary Shares |
c) | Price(s) and volume(s) | Volume - 1,792,500 Exercise Price - 4 pence |
d) | Aggregated information: | See 4c) above |
e) | Date of the transaction | 9 November 2017 |
f) | Place of the transaction | Outside of a trading venue |